Verrica Pharmaceuticals Inc. (VRCA) Social Stream



Verrica Pharmaceuticals Inc. (VRCA): $5.92

0.27 (+4.78%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

VERRICA PHARMACEUTICALS INC (VRCA) Price Targets From Analysts

Use the tables below to see what analysts covering VERRICA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 6 $25 $16 $19.833 $6.72 195.13%
2021-12-16 6 $25 $16 $19.5 $6.72 190.18%
2022-03-03 4 $25 $16 $19.5 $6.72 190.18%
2022-03-07 5 $25 $16 $19.5 $6.72 190.18%
2022-03-09 6 $25 $16 $19.571 $6.72 191.24%
2022-05-09 5 $25 $16 $19.285 $6.72 186.98%
2022-05-25 6 $25 $4 $16.714 $6.72 148.72%
2022-05-27 6 $20 $4 $15.285 $6.72 127.46%
2022-05-31 6 $20 $4 $14.142 $6.72 110.45%
2022-08-11 5 $20 $4 $13.166 $6.72 95.92%
2022-08-12 5 $20 $4 $13 $6.72 93.45%
2023-01-25 5 $18 $4 $11.6 $6.72 72.62%
2023-02-27 5 $18 $4 $12.2 $6.72 81.55%
2023-03-06 5 $15 $4 $10.75 $6.72 59.97%
2023-03-07 6 $15 $11 $12.5 $6.72 86.01%
2023-03-22 6 $13 $10 $11.25 $6.72 67.41%
2023-05-09 6 $15.001 $10 $12 $6.72 78.57%
2023-05-10 6 $15 $10 $12 $6.72 78.57%
2023-07-17 5 $15 $10 $12 $6.72 78.57%
2023-07-25 6 $15 $10 $11.666 $6.72 73.6%
2023-07-27 6 $15 $10 $11.833 $6.72 76.09%
2023-08-10 6 $15 $10 $12.166 $6.72 81.04%
2023-11-10 6 $15 $10 $12.666 $6.72 88.48%
2023-11-20 6 $18 $8 $12.833 $6.72 90.97%

The Trend in the Analyst Price Target


VRCA's average price target has moved down $1.31 over the prior 18 months.

Over the past 43 weeks, VRCA's average upside potential has been 132.44%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-22 6 13 10 11.250 6.370 76.61%
2023-06-26 5 15 10 12.000 5.500 118.18%
2023-10-12 6 15 10 12.666 3.650 247.01%
2023-11-10 6 15 10 12.666 3.075 311.9%
2023-11-20 6 18 8 12.833 3.710 245.9%

VRCA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 4 2 0 0 0 6

The Trend in the Broker Recommendations


VRCA's average broker recommendation rating worsened by 0.33 over the prior 45 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • VERRICA PHARMACEUTICALS INC's average analyst price target is higher than 489.81% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, VERRICA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2240.52% of them.
  • VERRICA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 671.8% of all US stocks.
  • In the context of Pharmaceutical Products stocks, VERRICA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1122.33% of them.

In the Pharmaceutical Products industry, ITRM, SLGL, and COGT are the three stocks most similar to VERRICA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding VRCA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!